Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Parkinson Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Not applicableStudy completedNCT03432338
What this trial is testing

Distribution of Non-Motor Symptoms in Idiopathic Parkinson's Disease and Secondary Parkinsonism

Who this might be right for
Parkinson Disease
Örjan Skogar 208
Large-scale testing (Phase 3)Study completedNCT01176240
What this trial is testing

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

Who this might be right for
Orthostatic HypotensionParkinson's Disease
Chelsea Therapeutics 225
Large-scale testing (Phase 3)Study completedNCT00180037
What this trial is testing

Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Technische Universität Dresden 132
Testing effectiveness (Phase 2)UnknownNCT02539784
What this trial is testing

Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease

Who this might be right for
Parkinson
Assistance Publique - Hôpitaux de Paris 6
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Large-scale testing (Phase 3)Study completedNCT00782340
What this trial is testing

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 263
Not applicableStudy completedNCT03301935
What this trial is testing

Risk Assessment in Patients With Symptomatic- and Asymptomatic Preexcitation

Who this might be right for
Wolff-Parkinson-White Syndrome
Karolinska University Hospital 168
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Testing effectiveness (Phase 2)Active Not RecruitingNCT05109364
What this trial is testing

Terazosin and Parkinson's Disease Extension Study

Who this might be right for
Symptomatic Parkinson DiseaseREM Sleep Behavior DisorderPre-motor Parkinson's Disease
Cedars-Sinai Medical Center 15
Post-approval studies (Phase 4)Study completedNCT01168596
What this trial is testing

Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Florida 30
Not applicableStudy completedNCT05273957
What this trial is testing

A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism.

Who this might be right for
Parkinson DiseaseAtypical ParkinsonismSecondary Parkinsonism+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 121
Testing effectiveness (Phase 2)Study completedNCT00273351
What this trial is testing

Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families

Who this might be right for
Parkinson DiseaseParkinsonian Syndrome
Institute for Neurodegenerative Disorders 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04218968
What this trial is testing

Cardiac Changes in Early Parkinson's Disease: A Follow up Study

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Cedars-Sinai Medical Center 15
Not applicableStudy completedNCT01360229
What this trial is testing

Acupuncture for Fatigue in Parkinson's Disease

Who this might be right for
Parkinsons Disease
University of Colorado, Denver 94
Testing effectiveness (Phase 2)Study completedNCT01341431
What this trial is testing

Bee Venom for the Treatment of Parkinson Disease

Who this might be right for
Parkinson Disease
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Study completedNCT04332276
What this trial is testing

Dopaminergic restauratIon by intraVEntriculaire Administration

Who this might be right for
Parkinson Disease
University Hospital, Lille 12
Not applicableUnknownNCT04589182
What this trial is testing

Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease

Who this might be right for
Parkinson DiseaseMild Cognitive ImpairmentHuntington Disease
Christian Baumann 12